Evidence map›Paper›PMID 27720016›Full record

ArticleThe Journal of allergy and clinical immunology2016

Asthma phenotypes in inner-city children.

Edward M Zoratti, Rebecca Z Krouse, Denise C Babineau, Jacqueline A Pongracic, George T O'Connor, Robert A Wood, Gurjit K Khurana Hershey, Carolyn M Kercsmar, Rebecca S Gruchalla, Meyer Kattan and 7 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01383941 (Asthma Phenotypes in the Inner City), which is not on this map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01383941 completednot on this map

Asthma Phenotypes in the Inner City (ICAC-19)

TypeobservationalSponsorNational Institute of Allergy and Infectious Diseases (NIAID)Ran2011 to 2014Enrolled717ConditionsAsthma, RhinitisArmsGuidelines-based asthma and rhinitis/rhinosinusitis therapy
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 147 citations in OpenAlex.

  1. Trial
  2. Treatment by biomarker-informed endotype vs guideline care in children with difficult-to-treat asthma.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Trial
  3. Review
  4. Review
  5. Cumulative genetic risk for asthma contributes to disease severity in children with asthma.The journal of allergy and clinical immunology. Global · 2026
    Article
  6. Context-specific genetic effects inform endotypes and treatment in asthma.The Journal of allergy and clinical immunology · 2026
    Article
  7. Article
  8. Associations between body weight, asthma burden, and type 2 inflammation among under-resourced children.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026
    Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Asthma Phenotypes and Biomarkers.Respiratory care · 2025
    Review
  15. Correlation between total IgE level and asthma symptom severity in hospitalized children.The journal of allergy and clinical immunology. Global · 2025
    Article
  16. Indoor bioaerosols and asthma: Overview, implications, and mitigation strategies.The Journal of allergy and clinical immunology · 2025
    Review
  17. Review
  18. Article
  19. Molecular allergen sensitization drives phenotypes of severe asthma in children: Evidence from a megacity cohort (SAMP).Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2024
    Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 1 country.

Edward M ZorattiHenry Ford Health System and Wayne State University School of Medicine, Detroit, Mich. Electronic address: ezoratt1@hfhs.org.
Rebecca Z KrouseRho Federal Systems Division, Chapel Hill, NC.
Denise C BabineauRho Federal Systems Division, Chapel Hill, NC.
Jacqueline A PongracicAnn and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill.
George T O'ConnorBoston University School of Medicine, Boston, Mass.
Robert A WoodJohns Hopkins University School of Medicine, Baltimore, Md.
Gurjit K Khurana HersheyCincinnati Children's Hospital, Cincinnati, Ohio.
Carolyn M KercsmarCincinnati Children's Hospital, Cincinnati, Ohio.
Rebecca S GruchallaUniversity of Texas Southwestern Medical Center, Dallas, Tex.
Meyer KattanCollege of Physicians and Surgeons, Columbia University, New York, NY.
Stephen J TeachChildren's National Health System and the George Washington University School of Medicine and Health Sciences, Washington, DC.
Steven M SigelmanNational Institutes of Allergy and Infectious Diseases, Bethesda, Md.
Peter J GergenNational Institutes of Allergy and Infectious Diseases, Bethesda, Md.
Alkis TogiasNational Institutes of Allergy and Infectious Diseases, Bethesda, Md.
Cynthia M VisnessRho Federal Systems Division, Chapel Hill, NC.
William W BusseUniversity of Wisconsin School of Medicine and Public Health, Madison, Wis.
Andrew H LiuNational Jewish Health, Denver, Colo; Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colo.
National Institute of Allergy and Infectious Diseases · USRho (United States) · USCincinnati Children's Hospital Medical Center · USBoston University · USChildren's National · USColumbia University · USHenry Ford Health System · USJohns Hopkins University · USLurie Children's Hospital · USNational Jewish Health · USThe University of Texas Southwestern Medical Center · USUniversity of Wisconsin–Madison · US

Funding

Transplantation GroupUM2AI117870 · NIAID · RHO FEDERAL SYSTEMS DIVISION, INC. · PI DAVID, GLORIA · 2015 to 2023
$208.1M
Inner City Asthma consortium 3 (ICAC3)UM1AI114271 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI GERN, JAMES E., JACKSON, DANIEL J · 2014 to 2021
$79.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Clinical and Translational Science AwardUL1TR000040 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GINSBERG, HENRY N · 2012 to 2015
$26.2M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
Clinical and Translational Science Institute at Children's NationalUL1TR000075 · NCATS · CHILDREN'S RESEARCH INSTITUTE · PI GUAY-WOODFORD, LISA MARIE · 2012 to 2015
$13.7M
Multidisciplinary Clinical and Translational Science (MCTS) Program (UL1)UL1TR000150 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LLOYD-JONES, DONALD M · 2012 to 2013
$10.1M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., TSEVAT, JOEL · 2012 to 2014
$9.9M
UT-Southwestern Clinical and Translational Alliance for Research (UT-STAR) (TL1)UL1TR000451 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2012 to 2012
$6.3M
NCATS NIH HHS UL1 TR000040NCATS NIH HHS UL1 TR000075NCATS NIH HHS UL1 TR000077NCATS NIH HHS UL1 TR000150NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000451NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR001105NCATS NIH HHS UL1 TR001422NCRR NIH HHS UL1 RR025780NIAID NIH HHS HHSN272200900052CNIAID NIH HHS HHSN272201000052INIAID NIH HHS UM1 AI114271NIAID NIH HHS UM2 AI117870
6 · The paper itself

Abstract

backgroundChildren with asthma in low-income urban areas have high morbidity. Phenotypic analysis in these children is lacking, but may identify characteristics to inform successful tailored management approaches.

objectiveWe sought to identify distinct asthma phenotypes among inner-city children receiving guidelines-based management.

methodsNine inner-city asthma consortium centers enrolled 717 children aged 6 to 17 years. Data were collected at baseline and prospectively every 2 months for 1 year. Participants' asthma and rhinitis were optimally managed by study physicians on the basis of guidelines. Cluster analysis using 50 baseline and 12 longitudinal variables was performed in 616 participants completing 4 or more follow-up visits.

resultsFive clusters (designated A through E) were distinguished by indicators of asthma and rhinitis severity, pulmonary physiology, allergy (sensitization and total serum IgE), and allergic inflammation. In comparison to other clusters, cluster A was distinguished by lower allergy/inflammation, minimally symptomatic asthma and rhinitis, and normal pulmonary physiology. Cluster B had highly symptomatic asthma despite high step-level treatment, lower allergy and inflammation, and mildly altered pulmonary physiology. Cluster C had minimally symptomatic asthma and rhinitis, intermediate allergy and inflammation, and mildly impaired pulmonary physiology. Clusters D and E exhibited progressively higher asthma and rhinitis symptoms and allergy/inflammation. Cluster E had the most symptomatic asthma while receiving high step-level treatment and had the highest total serum IgE level (median, 733 kU/L), blood eosinophil count (median, 400 cells/mm

conclusionsAllergy distinguishes asthma phenotypes in urban children. Severe asthma often coclusters with highly allergic children. However, a symptomatic phenotype with little allergy or allergic inflammation was identified.

Indexed as

PhenotypeUrban PopulationAdolescentAsthmaChildCluster AnalysisEpidemiologic StudiesHumansHypersensitivityPovertyProspective StudiesRhinitisSeverity of Illness IndexSocioeconomic FactorsUnited Statesairway inflammationAllergen sensitizationallergyasthma phenotypesasthma severitybronchial hyperresponsivenesshierarchical clusterIgEinner-city asthmarhinitis

Identifiers

PMID27720016
PMCPMC5104222
OpenAlexW2528725393

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.